[HTML][HTML] Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective

V Kumar, S Kundu, A Singh, S Singh - Current neuropharmacology, 2022 - ncbi.nlm.nih.gov
Neurodegenerative diseases are a group of pathological conditions that cause motor inc-
ordination (jerking movements), cognitive and memory impairments result from …

The role of altered protein acetylation in neurodegenerative disease

F Kabir, R Atkinson, AL Cook, AJ Phipps… - Frontiers in Aging …, 2023 - frontiersin.org
Acetylation is a key post-translational modification (PTM) involved in the regulation of both
histone and non-histone proteins. It controls cellular processes such as DNA transcription …

Epigenetic changes in prion and prion-like neurodegenerative diseases: Recent advances, potential as biomarkers, and future perspectives

A Hernaiz, JM Toivonen, R Bolea… - International journal of …, 2022 - mdpi.com
Prion diseases are transmissible spongiform encephalopathies (TSEs) caused by a
conformational conversion of the native cellular prion protein (PrPC) to an abnormal …

Potential therapeutic role of HDAC inhibitors in FUS-ALS

C Tejido, D Pakravan, LVD Bosch - Frontiers in Molecular …, 2021 - frontiersin.org
Mutations in the FUS gene cause amyotrophic lateral sclerosis (ALS-FUS). However, the
exact pathogenic mechanism of mutant fused in sarcoma (FUS) protein is not completely …

Transactive response DNA-binding protein (TARDBP/TDP-43) regulates cell permissivity to HIV-1 infection by acting on HDAC6

R Cabrera-Rodríguez, S Pérez-Yanes… - International journal of …, 2022 - mdpi.com
The transactive response DNA-binding protein (TARDBP/TDP-43) influences the processing
of diverse transcripts, including that of histone deacetylase 6 (HDAC6). Here, we assessed …

Axonopathy underlying amyotrophic lateral sclerosis: Unraveling complex pathways and therapeutic insights

T Luan, Q Li, Z Huang, Y Feng, D Xu, Y Zhou, Y Hu… - Neuroscience …, 2024 - Springer
Abstract Amyotrophic Lateral Sclerosis (ALS) is a complex neurodegenerative disorder
characterized by progressive axonopathy, jointly leading to the dying back of the motor …

Restoring Axonal Organelle Motility and Regeneration in Cultured FUS-ALS Motoneurons through Magnetic Field Stimulation Suggests an Alternative Therapeutic …

W Kandhavivorn, H Glaß, T Herrmannsdörfer… - Cells, 2023 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a devastating motoneuron disease characterized by
sustained loss of neuromuscular junctions, degenerating corticospinal motoneurons and …

Inhibition of HDAC6 with CAY10603 alleviates acute and chronic kidney injury by suppressing the ATF6 branch of UPR

S Kan, Q Hou, R Yang, F Yang, M Zhang, Z Liu… - Archives of Biochemistry …, 2024 - Elsevier
Abstract Background Histone deacetylase 6 (HDAC6) inhibitor CAY10603 has been
identified as a potential therapeutic agent for the treatment of diabetic kidney disease (DKD) …

A molecular view of amyotrophic lateral sclerosis through the lens of interaction network modules

KH Jensen, AK Stalder, R Wernersson… - Plos one, 2022 - journals.plos.org
Background Despite the discovery of familial cases with mutations in Cu/Zn-superoxide
dismutase (SOD1), Guanine nucleotide exchange C9orf72, TAR DNA-binding protein 43 …

[PDF][PDF] The role of altered protein acetylation in neurodegenerative

F Kabir, R Atkinson, AL Cook, AJ Phipps, AE King - 2023 - figshare.utas.edu.au
Post-translational modifications (PTMs) of proteins define the molecular complexity of our
cells. Through mechanisms such as covalent modifications of proteins, PTMs change the …